Get started
Author

Pierre Guéret

Observed names: Gueret, P., Gueret, Pierre, Guéret, Pierre, P Gueret, P. GUERET, P. Gueret, Pierre Gueret, Pierre Guéret
OpenAlex ID: A5073604151
Prospective evaluation of the ‘4Ts’ score and particle gel immunoassay specific to heparin/PF4 for the diagnosis of heparin‐induced thrombocytopenia
2007 · C. POUPLARD, P. GUERET, et al. · Journal of Thrombosis and Haemostasis · 188
Large external quality assessment survey on thrombin generation with CAT: further evidence for the usefulness of normalisation with an external reference plasma
2014 · Julien Perrin, François Depasse, et al. · Thrombosis Research · 68
Comparative effects of dietary n-3 docosapentaenoic acid (DPA), DHA and EPA on plasma lipid parameters, oxidative status and fatty acid tissue composition
2018 · Gaetan Drouin, Daniel Catheline, et al. · The Journal of Nutritional Biochemistry · 63
Identification and quantification of fetal red blood cells in maternal blood by a dual‐color flow cytometric method: evaluation of the Fetal Cell Count kit
2007 · Valérie Porra, Janine Bernaud, et al. · Transfusion · 63
A New Reversible and Potent P2Y12 Receptor Antagonist (ACT-246475): Tolerability, Pharmacokinetics, and Pharmacodynamics in a First-in-Man Trial
2014 · Daniela Baldoni, Shirin Bruderer, et al. · Clinical Drug Investigation · 41
Leiden factor V mutation in four patients with small bowel infarctions
1997 · D Heresbach, M Pagenault, et al. · Gastroenterology · 37
PDF
Safety of recombinant factor VIIa in patients under extracorporeal membrane oxygenation
2015 · Amedeo Anselmi, Patrick Guinet, et al. · European Journal of Cardio-Thoracic Surgery · 33
PDF
Management of Therapeutic-intensity Unfractionated Heparin: A Narrative Review on Critical Points
2024 · Isabelle Gouin-Thibault, Alexandre Mansour, et al. · TH Open · 28
PDF
Apixaban and rivaroxaban in obese patients treated for venous thromboembolism: Drug levels and clinical outcomes
2021 · Alice Ballerie, Rémi Nguyen Van, et al. · Thrombosis Research · 21
First in man study of EP217609, a new long-acting, neutralisable parenteral antithrombotic with a dual mechanism of action
2016 · Pierre Gueret, S. Combe, et al. · European Journal of Clinical Pharmacology · 8
Tinzaparin, an alternative to subcutaneous unfractionated heparin, in patients with severe and end-stage renal impairment: a retrospective observational single-center study
2024 · Isabelle Gouin-Thibault, Alexandre Mansour, et al. · Journal of Thrombosis and Haemostasis · 7
PDF
A performance evaluation of sthemO 301 coagulation analyzer and associated reagents
2023 · Adeline Pontis, Mélanie Delanoe, et al. · Journal of Clinical Laboratory Analysis · 7
PDF
Oral Janus kinase inhibitors and venous thromboembolic events in atopic dermatitis: protocols for a case–time control study and a nested case-control study based on the French national health insurance (SNDS) cohort
2022 · Pauline Berthe, Lucie-Marie Scailteux, et al. · BMJ Open · 7
PDF
Thrombin generation in patients with acquired haemophilia and clinical bleeding risk
2011 · Arnaud Millet, Julie Graveleau, et al. · British Journal of Haematology · 7
PDF
Myocardial infarction and thrombophilia: Do not miss the right diagnosis!
2017 · Arnaud Hubert, Pierre Guéret, et al. · Revista Portuguesa de Cardiologia · 5
PDF
Neutralization of EP217609, a new dual-action FIIa/FXa anticoagulant, by its specific antidote avidin: a phase I study
2016 · P. Gueret, S. Combe, et al. · European Journal of Clinical Pharmacology · 5
EP42675, a synthetic parenteral dual‐action anticoagulant: pharmacokinetics, pharmacodynamics, and absence of interactions with antiplatelet drugs
2013 · P. Gueret, C. Krezel, et al. · Journal of Thrombosis and Haemostasis · 5
PDF
Impact of age on in vitro metabolism of clopidogrel: a potential explanation for high on-treatment platelet reactivity in the elderly?
2023 · Adeline Pontis, Xavier Delavenne, et al. · Research and Practice in Thrombosis and Haemostasis · 4
Management of a High-Risk Surgery with Emicizumab and Factor VIII in a Child with a Severe Hemophilia A and Inhibitor
2021 · Charles R. Lefèvre, Anaïs Jaffré, et al. · TH Open · 4
PDF
Myocardial infarction and thrombophilia: Do not miss the right diagnosis!
2018 · Arnaud Hubert, Pierre Guéret, et al. · Revista Portuguesa de Cardiologia (English Edition) · 4
PDF
La recherche de thrombophilie héréditaire et son impact thérapeutique dans la maladie thromboembolique veineuse : résultats d’une étude monocentrique rétrospective sur 162 patients
2016 · J.-S. Allain, P. Gueret, et al. · La Revue de Médecine Interne · 3
EP42675, a New Dual Action Anticoagulant: Pharmacodynamic and Pharmacokinetic Profile, and Interactions with Acetylsalicylic Acid, Clopidogrel, and Unfractionated Heparin.
2009 · Pierre Gueret, Chantal Krezel, et al. · Blood · 2
Heparin‐induced thrombocytopenia leading to a diagnosis of essential thrombocythemia
2021 · Adeline Pontis, Jessica Valaize, et al. · International Journal of Laboratory Hematology · 1
PDF
Cadre réglementaire pour les médicaments dérivés du sang. Utilisation en Odontologie et en Chirurgie Buccale Etude descriptive de 46 interventions sur la période 2003 à 2004
2005 · Julien Garnier, Xavier Frachon, et al. · Médecine Buccale Chirurgie Buccale · 1
PDF
Ulcère athéromateux pénétrant de l'aorte thoracique. A propos d'un cas.
1996 · Michel Habis, F Pouillart, et al. · Archives Des Maladies Du Coeur Et Des Vaisseaux · 1
Works count: 35
Citation count: 613
H-index: 9
I10-index: 9
Year
Topic
Type